Article
Seq2Neo: a comprehensive pipeline for cancer neoantigen immunogenicity prediction
2022-09-16
Abstract excerpt
Neoantigens derived from somatic DNA alterations are ideal cancer-specific targets. In recent years, the combination therapy of PD-1/PD-L1 blockers and neoantigen vaccines shows clinical efficacy in original PD-1/PD-L1 blocker non-responders. However, not all somatic DNA mutations can result in immunogenicity in cancer cells, and efficient tools for predicting the immunogenicity of neoepitope are still urgently ne...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 55b5bb3a-cb6d-52dc-a44c-9cfcd6ed29b7
- DOI
- 10.1101/2022.09.14.507872
